Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia.

Browne S, Roe M, Lane A, Gervin M, Morris M, Kinsella A, Larkin C, Callaghan EO.

Acta Psychiatr Scand. 1996 Aug;94(2):118-24.

PMID:
8883573
2.

Treatment-resistant schizophrenia--the role of clozapine.

Meltzer HY.

Curr Med Res Opin. 1997;14(1):1-20. Review.

PMID:
9524789
4.

Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol.

Oosthuizen PP, Emsley RA, Maritz JS, Turner JA, Keyter N.

J Clin Psychiatry. 2003 Sep;64(9):1075-80.

PMID:
14628983
5.

Relationship of clinical and demographic characteristics of schizophrenia patients to rehabilitation status.

Rigbi A, Shalev-Mevorach L, Taller A, Taller Y, Lerer B.

Isr J Psychiatry Relat Sci. 2003;40(4):258-67.

PMID:
14971127
6.

The natural history of tardive dystonia. A long-term follow-up study of 107 cases.

Kiriakakis V, Bhatia KP, Quinn NP, Marsden CD.

Brain. 1998 Nov;121 ( Pt 11):2053-66.

PMID:
9827766
7.

[Evaluation of health-related quality of life in hospitalized schizophrenics].

Konieczyńska Z, Jarema M, Cikowska G.

Psychiatr Pol. 1997 May-Jun;31(3):323-31. Polish.

PMID:
9527677
8.

Predictors and course of vocational status, income, and quality of life in people with severe mental illness: a naturalistic study.

Nordt C, Müller B, Rössler W, Lauber C.

Soc Sci Med. 2007 Oct;65(7):1420-9. Epub 2007 Jun 20.

PMID:
17583402
9.

[Relationships between insight and medication adherence in subjects with psychosis].

Droulout T, Liraud F, Verdoux H.

Encephale. 2003 Sep-Oct;29(5):430-7. French.

PMID:
14615692
10.

Quality of life of Chinese schizophrenia outpatients in Hong Kong: relationship to sociodemographic factors and symptomatology.

Xiang YT, Weng YZ, Leung CM, Tang WK, Ungvari GS.

Aust N Z J Psychiatry. 2007 May;41(5):442-9.

PMID:
17464737
11.

[Comparison of quality of life of schizophrenic patients in different forms of psychiatric care].

Jarema M, Bury L, Konieczyńska Z, Zaborowski B, Cikowska G, Kunicka A, Bartoszewicz J, Muraszkiewicz L.

Psychiatr Pol. 1997 Sep-Oct;31(5):585-94. Polish.

PMID:
9547184
12.

Hospital and community-based care for patients with chronic schizophrenia in Hong Kong--quality of life and its correlates.

Chan GW, Ungvari GS, Shek DT, Leung Dagger JJ.

Soc Psychiatry Psychiatr Epidemiol. 2003 Apr;38(4):196-203.

PMID:
12664230
13.

A comparison of quality-of-life in schizophrenia and affective disorder patients in a Nigerian tertiary hospital.

Bamiso Makanjuola A, Ademola Adeponle B, Ayodele Obembe O.

Transcult Psychiatry. 2007 Mar;44(1):65-78.

PMID:
17379611
14.
15.

Health-related quality of well-being in chronically hospitalized patients with schizophrenia: comparison with matched outpatients.

Kasckow JW, Twamley E, Mulchahey JJ, Carroll B, Sabai M, Strakowski SM, Patterson T, Jeste DV.

Psychiatry Res. 2001 Aug 5;103(1):69-78.

PMID:
11472791
16.

Predictors of subjective and objective quality of life in outpatients with schizophrenia.

Yamauchi K, Aki H, Tomotake M, Iga J, Numata S, Motoki I, Izaki Y, Tayoshi S, Kinouchi S, Sumitani S, Tayoshi S, Takikawa Y, Kaneda Y, Taniguchi T, Ishimoto Y, Ueno S, Ohmori T.

Psychiatry Clin Neurosci. 2008 Aug;62(4):404-11. doi: 10.1111/j.1440-1819.2008.01818.x.

17.

Worsening of psychosis in schizophrenia is longitudinally associated with tardive dyskinesia in the European Schizophrenia Outpatient Health Outcomes study.

Tenback DE, van Harten PN, Slooff CJ, van Os J; SOHO Study Group.

Compr Psychiatry. 2007 Sep-Oct;48(5):436-40. Epub 2007 Jul 5.

PMID:
17707251
18.

Schizophrenia with prominent catatonic features ('catatonic schizophrenia'): I. Demographic and clinical correlates in the chronic phase.

Ungvari GS, Leung SK, Ng FS, Cheung HK, Leung T.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jan;29(1):27-38.

PMID:
15610942
19.
20.

[Subjective quality of life of schizophrenic patients. Effect of treatment setting, psychopathology and extrapyramidal motor drug effects].

Kemmler G, Meise U, Tasser A, Liensberger D, Schifferle I, Braitenberg M, Schwitzer J, Hinterhuber H.

Psychiatr Prax. 1999 Jan;26(1):9-15. German.

PMID:
10087570

Supplemental Content

Support Center